05/06/2021
6:09 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2021
6:09 AM | BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2021
9:57 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2021
7:21 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2021
8:36 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
04/02/2021
4:26 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2021
1:02 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2021
7:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2021
3:41 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/02/2021
3:53 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/02/2021
3:50 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2021
3:47 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2021
6:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2021
8:19 AM | BioCryst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2021
3:40 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2021
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2021
3:34 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
3:25 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
2:16 PM | BioCryst Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/11/2021
11:54 AM | BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A
| |
02/10/2021
3:28 PM | BioCryst Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A
| |
02/05/2021
10:42 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/03/2021
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2021
3:43 PM | BioCryst Pharmaceuticals (Subject)
Sarissa Capital Management LP (Filed by)
| Form SC 13G
| |
01/22/2021
6:12 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2020
7:16 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2020
6:03 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2020
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2020
3:45 PM | BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:41 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:37 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:32 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:30 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:27 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:23 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:20 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2020
4:35 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2020
6:14 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
12/08/2020
3:12 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:24 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:23 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:21 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:19 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:16 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
8:34 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2020
8:34 AM | BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2020
3:21 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
3:19 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
3:16 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
3:14 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2020
3:25 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
6:12 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2020
6:10 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2020
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2020
3:44 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2020
3:39 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2020
3:36 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2020
3:33 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2020
10:21 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2020
6:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2020
3:35 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2020
3:31 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2020
6:25 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2020
6:14 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2020
4:07 PM | BioCryst Pharmaceuticals (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G
| |
06/10/2020
3:32 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2020
3:32 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2020
3:31 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/01/2020
7:30 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2020
5:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 424B2
| |
05/27/2020
4:16 PM | BioCryst Pharmaceuticals (Filer)
| Form 424B5
| |
05/15/2020
3:20 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
11:15 PM | BioCryst Pharmaceuticals (Filer)
| Form EFFECT
| |
05/14/2020
3:36 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
3:21 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
3:18 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2020
6:15 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2020
7:55 AM | BioCryst Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/17/2020
4:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SC 13G
| |
04/09/2020
7:11 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2020
9:51 AM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2020
6:55 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2020
11:53 AM | BioCryst Pharmaceuticals (Filer)
| Form DEFA14A
| |
03/31/2020
11:52 AM | BioCryst Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/30/2020
6:20 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2020
3:15 PM | BioCryst Pharmaceuticals (Filer)
| Form PRE 14A
| |
03/13/2020
2:36 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/10/2020
8:26 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2020
6:24 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2020
6:24 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2020
3:49 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2020
3:42 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2020
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
4:13 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
4:11 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:57 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:53 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
3:20 PM | BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A
| |
02/14/2020
3:14 PM | BAKER BROS. ADVISORS LP (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SC 13G/A
| |
